Journal
JOURNAL OF LIPID RESEARCH
Volume 49, Issue 1, Pages 162-168Publisher
ELSEVIER
DOI: 10.1194/jlr.M700406-JLR200
Keywords
bipolar disorder; signaling; neuroreceptor
Categories
Funding
- NATIONAL INSTITUTE ON AGING [ZIAAG000151, Z01AG000151] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Whereas antibipolar drug administration to rats reduces brain arachidonic acid turnover, excessive N-methyl-D-aspartate (NMDA) signaling is thought to contribute to bipolar disorder symptoms and may increase arachidonic acid turnover in rat brain phospholipids. To determine whether chronic NMDA would increase brain arachidonic acid turnover, rats were daily administered NMDA (25 mg/kg, ip) or vehicle for 21 days. In un-anesthetized rats, on day 21, [1-C-14] arachidonic acid was infused intravenously and arterial blood plasma was sampled until the animal was euthanized at 5 min and its microwaved brain was subjected to chemical and radio-tracer analysis. Using equations from our in vivo fatty acid model, we found that compared with controls, chronic NMDA increased the net rate of incorporation of plasma unesterified arachidonic acid into brain phospholipids (25-34%) as well as the turnover of arachidonic acid within brain phospholipids (35-58%). These changes were absent at 3 h after a single NMDA injection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available